Background: Individuals with intrauterine growth retardation (IUGR) who demonstrate a catch-up in body weight are prone to insulin resistance. high expressions of suppressor of cytokine signaling 3 (sOcs3) are thought to aggravate insulin resistance. We hypothesized that downregulating sOcs3 expression via small interfering RNa (siRNa) might have beneficial effects on insulin-resistant hepatocytes of catch-up growth IUGR rats (cG-IUGRs). Methods: an IUGR rat model was employed via maternal nutritional restriction. after evaluating metabolic states of cG-IUGR offspring, effective SOCS3-specific siRNa (sisOcs3) was transfected into cultured hepatocytes using liposomes. mRNa levels of sOcs3, insulin receptor substrates (IRss), phosphatidylinositol 3-kinase (PI3K), and akt2, key gluconeogenesis genes, were assessed via real-time PcR. Protein expression and phosphorylation changes were evaluated via western blot. results: cG-IUGR hepatocytes showed increases in sOcs3 and gluconeogenic gene expressions, and decreases in IRs1 and PI3K expressions as compared with controls. after transfecting cG-IUGR hepatocytes with sisOcs3, protein levels of IRs1, PI3K, and phosphorylated akt2 were higher as compared with those of untransfected cG-IUGR cells. Transcriptional suppression effects of gluconeogenesis genes were more obvious in sisOcs3-treated cells after insulin stimulation. conclusion: additional insights were provided to understand mechanisms of insulin resistance in cG-IUGR rats. Downregulating sOcs3 might improve insulin signaling transduction and ameliorate hepatic glucose metabolism in insulin-resistant cG-IUGR rats in vitro.W orldwide epidemiological data have shown that intrauterine growth retardation (IUGR), low birth weight, and subsequent adulthood obesity are highly correlated with the development of metabolic syndrome, which comprises hypertension, cardiovascular disease, type 2 diabetes mellitus, and dyslipidemia. Insulin resistance is considered to be a fundamental contributor to metabolic syndrome (1-3). The underlying causes of IUGR are complicated. In developed countries, poor placental function and cigarette smoking during pregnancy are the most common factors causing IUGR, although maternal malnutrition is the major determinant of IUGR in developing countries (4). Approximately 85-90% of infants with IUGR demonstrate catch-up growth during the first 2 y, and those who display a catch-up in body weight are more prone to insulin resistance (5). However, the underlying molecular mechanisms that result in insulin resistance in individuals with catch-up IUGR are still not fully understood.Suppressor of cytokine signaling (SOCS)-family proteins have been identified as inhibitors of cytokine-induced signaling pathways in various tissues and serve as physiological regulatory feedback loops (6). Suppressor of cytokine signaling 3 (SOCS3) is highly expressed in the liver, skeletal muscle, and adipose tissue of animal models with insulin resistance (7,8). Studies have also shown that SOCS3 plays an important role...